| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Richard E Hodgso. Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting. ClinicoEconomics and outcomes research : CEOR. vol 11. 2020-09-30. PMID:31616168. |
antipsychotics are an effective treatment option for patients with schizophrenia and several long-acting injectables (lais), including risperidone, olanzapine, paliperidone, and aripiprazole are available in the uk. |
2020-09-30 |
2023-08-13 |
Not clear |
| B Yu, J X Zhao, B Shi, Y H Zhu, C Che. [Effect of risperidone on prepulse inhibition of the startle reflex and P50 deficit in patients with first-episode and chronic schizophrenia]. Zhonghua yi xue za zhi. vol 100. issue 36. 2020-09-30. PMID:32988144. |
[effect of risperidone on prepulse inhibition of the startle reflex and p50 deficit in patients with first-episode and chronic schizophrenia]. |
2020-09-30 |
2023-08-13 |
Not clear |
| Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, Frank R Erns. A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia. Annals of general hospital psychiatry. vol 3. issue 1. 2020-09-29. PMID:15175112. |
a comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia. |
2020-09-29 |
2023-08-12 |
human |
| Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, Frank R Erns. A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia. Annals of general hospital psychiatry. vol 3. issue 1. 2020-09-29. PMID:15175112. |
this prospective observational study compared olanzapine and risperidone on one-year psychiatric hospitalization rate, duration, and time to hospitalization in the treatment of patients with schizophrenia in usual care. |
2020-09-29 |
2023-08-12 |
human |
| Roya Samadi, Susan Soluti, Reza Daneshmand, Shervin Assari, Ali Akhoundpour Mantegh. Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial. Iranian journal of medical sciences. vol 42. issue 1. 2020-09-29. PMID:28293046. |
efficacy of risperidone augmentation with ondansetron in the treatment of negative and depressive symptoms in schizophrenia: a randomized clinical trial. |
2020-09-29 |
2023-08-13 |
Not clear |
| Roya Samadi, Susan Soluti, Reza Daneshmand, Shervin Assari, Ali Akhoundpour Mantegh. Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial. Iranian journal of medical sciences. vol 42. issue 1. 2020-09-29. PMID:28293046. |
given the potential role of the 5-hydroxytryptamine-3 receptor in the pathogenesis of schizophrenia, this study was performed to determine whether ondansetron plus risperidone could reduce the negative and depressive symptoms in patients with treatment-resistant schizophrenia. |
2020-09-29 |
2023-08-13 |
Not clear |
| Gisela Paula González, Nebel Silvana Moscoso, Fernando Pablo Lag. A Review of Clinical and Economic Evaluations Applied to Psychotropic Therapies Used in the Treatment of Schizophrenia in Argentina. PharmacoEconomics - open. vol 2. issue 3. 2020-09-29. PMID:29623634. |
in this paper we seek to review the clinical and economic benefits of prescribing psychotropic therapies based on haloperidol (a first-generation antipsychotic that is part of the butyrophenone group of drugs) versus risperidone [an atypical or second-generation antipsychotic (neuroleptic) drug] in adult patients who have been diagnosed with schizophrenia. |
2020-09-29 |
2023-08-13 |
Not clear |
| Muneto Izuhara, Hiroyuki Matsuda, Ami Saito, Maiko Hayashida, Syoko Miura, Arata Oh-Nishi, Ilhamuddin Abdul Azis, Rostia Arianna Abdullah, Keiko Tsuchie, Tomoko Araki, Arauchi Ryousuke, Misako Kanayama, Sadayuki Hashioka, Rei Wake, Tsuyoshi Miyaoka, Jun Horiguch. Cognitive Behavioral Therapy for Insomnia as Adjunctive Therapy to Antipsychotics in Schizophrenia: A Case Report. Frontiers in psychiatry. vol 9. 2020-09-29. PMID:29946274. |
the authors present the case of a 38-year-old man with schizophrenia and with severe insomnia, who attempted suicide twice during oral drug therapy with risperidone. |
2020-09-29 |
2023-08-13 |
Not clear |
| Elyse J Cadena, David M White, Nina V Kraguljac, Meredith A Reid, Jose O Maximo, Eric A Nelson, Brian A Gawronski, Adrienne C Laht. A Longitudinal Multimodal Neuroimaging Study to Examine Relationships Between Resting State Glutamate and Task Related BOLD Response in Schizophrenia. Frontiers in psychiatry. vol 9. 2020-09-29. PMID:30555359. |
we used single voxel mrs acquired in the bilateral dorsal anterior cingulate cortex (acc) and fmri during performance of a stroop color-naming task in 22 patients with schizophrenia (sz), initially off-medication and after a 6-week course of risperidone, and 20 matched healthy controls (hc) twice, 6 weeks apart. |
2020-09-29 |
2023-08-13 |
Not clear |
| Takahiko Nagamin. Complete Recovery from Cardiac Arrest Caused by Risperidone-induced Hypothermia. Innovations in clinical neuroscience. vol 13. issue 11-12. 2020-09-28. PMID:28210523. |
we describe a patient with schizophrenia who was taking risperidone and who, after falling into a hypothermic state, suffered cardiac arrest. |
2020-09-28 |
2023-08-13 |
Not clear |
| Bir S Chavan, Gurjit Kaur, Deepti Gupta, Jitender Anej. A Prospective Study to Evaluate the Effect of CYP2D6 Polymorphism on Plasma level of Risperidone and its Metabolite in North Indian Patients with Schizophrenia. Indian journal of psychological medicine. vol 40. issue 4. 2020-09-28. PMID:30093744. |
a prospective study to evaluate the effect of cyp2d6 polymorphism on plasma level of risperidone and its metabolite in north indian patients with schizophrenia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Bir S Chavan, Gurjit Kaur, Deepti Gupta, Jitender Anej. A Prospective Study to Evaluate the Effect of CYP2D6 Polymorphism on Plasma level of Risperidone and its Metabolite in North Indian Patients with Schizophrenia. Indian journal of psychological medicine. vol 40. issue 4. 2020-09-28. PMID:30093744. |
so, we attempted to evaluate the relationship between cyp2d6*10 (rs1065852) and cyp2d6*4 (rs3892097) gene polymorphism and the plasma concentration of risperidone and its metabolite in patients with schizophrenia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Nina V Kraguljac, Charity J Morgan, Meredith A Reid, David M White, Ripu D Jindal, Soumya Sivaraman, Bridgette K Martinak, Adrienne C Laht. A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia. Schizophrenia research. vol 210. 2020-09-28. PMID:30630705. |
a longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Trisna Marni, Bahagia Loebis, Vita Camellia, Elmeida Effendy, Nazli Mahdinasari Nasutio. The Difference of Fasting Blood Sugar of Male Patients with Schizophrenia Treated with Flexible Dose between Aripiprazole and Risperidone in Medan, Indonesia. Open access Macedonian journal of medical sciences. vol 7. issue 9. 2020-09-28. PMID:31198452. |
the difference of fasting blood sugar of male patients with schizophrenia treated with flexible dose between aripiprazole and risperidone in medan, indonesia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Charmi Patel, Bruno Emond, Marie-Hélène Lafeuille, Aurélie Côté-Sergent, Patrick Lefebvre, Neeta Tandon, Antoine C El Khour. Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate. Drugs - real world outcomes. vol 7. issue 1. 2020-09-28. PMID:31786737. |
real-world analysis of switching patients with schizophrenia from oral risperidone or oral paliperidone to once-monthly paliperidone palmitate. |
2020-09-28 |
2023-08-13 |
Not clear |
| Lesia V Tchobaniouk, Erin E McAllister, Danielle L Bishop, Rachel M Carpentier, Katharine R Heins, Robert J Haight, Jeffrey R Bisho. Once-Monthly Subcutaneously Administered Risperidone in the Treatment of Schizophrenia: Patient Considerations. Patient preference and adherence. vol 13. 2020-09-28. PMID:32184570. |
once-monthly subcutaneously administered risperidone in the treatment of schizophrenia: patient considerations. |
2020-09-28 |
2023-08-13 |
Not clear |
| Grace Owusu Aboagye, Daniel Ankra. Drug-Drug-Induced Akathisia: Two Case Reports. Case reports in psychiatry. vol 2020. 2020-09-28. PMID:32373382. |
case a is a patient with schizophrenia who was being managed with risperidone 2 mg tablet daily for the past 3 years. |
2020-09-28 |
2023-08-13 |
Not clear |
| Keith H Nuechterlein, Joseph Ventura, Kenneth L Subotnik, Denise Gretchen-Doorly, Luana R Turner, Laurie R Casaus, John Luo, Michael L Boucher, Jacqueline N Hayata, Morris D Bell, Alice Medali. A randomized controlled trial of cognitive remediation and long-acting injectable risperidone after a first episode of schizophrenia: improving cognition and work/school functioning. Psychological medicine. 2020-09-28. PMID:32981534. |
a randomized controlled trial of cognitive remediation and long-acting injectable risperidone after a first episode of schizophrenia: improving cognition and work/school functioning. |
2020-09-28 |
2023-08-13 |
Not clear |
| Daisy Ng-Mak, Andrew Messali, Ahong Huang, Li Wang, Antony Loebe. Hospitalization risk in patients with schizophrenia treated with dose-equivalent antipsychotics. The American journal of managed care. vol 25. issue 14 Suppl. 2020-09-23. PMID:31365818. |
this study compared the risk of hospitalization among adults with schizophrenia being treated with equivalent dose ranges of lurasidone versus aripiprazole, olanzapine, quetiapine, or risperidone. |
2020-09-23 |
2023-08-13 |
Not clear |
| Xiaofen Zong, Maolin Hu, Spiro P Pantazatos, J John Mann, Gaohua Wang, Yanhui Liao, Zhong-Chun Liu, Wei Liao, Tao Yao, Zongchang Li, Ying He, Luxian Lv, Deen Sang, Jinsong Tang, Huafu Chen, Junjie Zheng, Xiaogang Che. A Dissociation in Effects of Risperidone Monotherapy on Functional and Anatomical Connectivity Within the Default Mode Network. Schizophrenia bulletin. vol 45. issue 6. 2020-09-16. PMID:30508134. |
we performed diffusion tensor imaging (dti) and resting-state functional magnetic resonance imaging in 42 drug-naive first-episode schizophrenia patients (fesp) both at baseline and after 8-weeks risperidone monotherapy, and in 38 healthy volunteers. |
2020-09-16 |
2023-08-13 |
human |